CN1346642A - 降糖茶 - Google Patents

降糖茶 Download PDF

Info

Publication number
CN1346642A
CN1346642A CN 00112591 CN00112591A CN1346642A CN 1346642 A CN1346642 A CN 1346642A CN 00112591 CN00112591 CN 00112591 CN 00112591 A CN00112591 A CN 00112591A CN 1346642 A CN1346642 A CN 1346642A
Authority
CN
China
Prior art keywords
tea
blood
egc
egcg
tps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 00112591
Other languages
English (en)
Inventor
徐建国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 00112591 priority Critical patent/CN1346642A/zh
Publication of CN1346642A publication Critical patent/CN1346642A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种降糖茶由切细绿茶等组成,其特征在于在切细绿茶的基础上按一定比例添加了茶多糖(TPS)、茶多酚(色素)、茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)等微量元素,利用切细绿茶的利尿、茶多糖、茶多酚、茶儿茶素的降血糖、降血脂、抗氧化等机理;制成袋装粉剂、水剂或膏剂等,达到标本兼治、易吸收之目的,是防治和治疗糖尿最理想的制剂之一。

Description

降糖茶
本发明涉及一种茶,特别涉及一种用于冶疗糖尿病的降糖茶。
糖尿病是由于身体胰岛素分泌减少,引起糖、脂肪、蛋白质、水和无机盐代谢紊乱,而致血糖升高和排泄糖尿的一种慢性病。病因尚未完全明确,可能与遗传、病毒感染、自身免疫等因素有关。患者多中老年以上。是仅次于癌症的第三大“杀手”。目前,西医采用调节血糖的方法《糖尿病保健新知识》(阎德文著,海天出版社出版),常见的有:1.磺脲类降糖药,此药刺激胰岛细胞释放胰岛素而发挥降糖作用,通常会将正常血糖降低,发生低血糖症;2.双胍类降糖药{主要有苯乙双胍(降糖灵)、二甲双胍(降糖片)},此药能延缓葡萄糖在肠道内吸收,但会造成胃肠道反应,出现口干苦、恶心、厌食、腹泻等症状;3.葡萄糖苷酶抑制剂,此药只有当消化道中存在双糖时,才显示它的作用,服药后会出现腹胀、腹泻等消化道反应;4.餐时血糖调节剂,该药是进一步快速促进胰岛细胞释放胰岛素的非磺脲类药物,该药必须在就餐时同时服用,影响食欲,使用不方便。中医药诊治糖尿病(《糖尿病及其并发症中西医诊治学》,吕仁和主编,人民出版社出版),需要诊断明确,中医辩证清楚,治疗中应用标本缓急恰当,选用处方准确,诊治分虚证(正虚)、实证(邪实)等几十种,对医生的业务素质要求较高。民间对糖病的诊治主要是利尿(《茶酒祛百病》。阎向编著,东方出版社出版):姜盐茶:觧生姜2片、食盐4.5g、绿茶6g冲水,由于大量的盐份进入体内,会造成心脏负担加重。
本发明的目的是提供一种使用方便,疗效好,无毒附作用的降糖茶。
本发明的实质是在切细绿茶的基础上添加了茶多糖(TPS)、茶多酚(色素)、茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)等微量元素,其配方为:
茶多糖(TPS)≥0.03%(重量百分比,以下同);
茶多酚(色素)≥10%:
茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)≥1.5%;
切细绿茶其余。
本发明的一个实施例:切细绿茶784.5g、茶多糖0.5g、茶多酚150g、茶儿茶素65g制成1000g粉剂,采用2.5g/袋袋装,;每袋用100~300ml温开水冲泡,每日饮用三次,一个疗程(180袋),通过检查,降糖总有效率达82.1%,降脂总有效率达91.5%。
本发明的另一个实施例:切细绿茶749g、茶多糖1g、茶多酚200g、茶儿茶素50g、加水9000g制成2000g水剂,采用250g/瓶瓶装;每日饮用三次,每次25g,一个疗程(18瓶),通过检查,降糖总有效率达81.8%,降脂总有效率大于90%。
本发明是利用切细绿茶的利尿等作用、茶多糖的降血糖、降血脂、抗炎症、降血压等功能、茶多酚的抗氧化、抗基因突变等功效和茶儿茶素的抗脑血管疾病、抗血管粥样硬化等机理,达到标本兼治之目的。加之将降糖茶制成袋装粉剂、水剂或膏剂,方便服用,是预防和治疗糖尿病理想制剂之一。

Claims (3)

1.一种降糖茶由切细绿茶等组成,其特征在于在切细绿茶的基础上添加了茶多糖(TPS)、茶多酚(色素)、茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)等微量元素。
2.根据权利要求1所述的降糖茶,其配方为:
茶多糖(TPS)≥0.03%(重量百分比,下同);
茶多酚(色素)≥10%;
茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)≥1.5%;
切细绿茶,其余。
3.根据权利要求1和2所述的降糖茶,其特征在于在权利要求2配方的基础上制成粉剂或加适量的水制成水剂。
CN 00112591 2000-10-08 2000-10-08 降糖茶 Pending CN1346642A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00112591 CN1346642A (zh) 2000-10-08 2000-10-08 降糖茶

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00112591 CN1346642A (zh) 2000-10-08 2000-10-08 降糖茶

Publications (1)

Publication Number Publication Date
CN1346642A true CN1346642A (zh) 2002-05-01

Family

ID=4582441

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00112591 Pending CN1346642A (zh) 2000-10-08 2000-10-08 降糖茶

Country Status (1)

Country Link
CN (1) CN1346642A (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967030B2 (en) * 2003-01-14 2005-11-22 Wright Jonathan V Formulation for insulin and glucose control
CN1792205B (zh) * 2004-12-24 2010-05-12 花王株式会社 绿茶提取物的精制品及其含高浓度儿茶素的容器装饮料
CN109549987A (zh) * 2017-09-25 2019-04-02 株式会社爱茉莉太平洋 用于保护细胞免受氧化应激的、包含具有改进量的成分的绿茶提取物的组合物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6967030B2 (en) * 2003-01-14 2005-11-22 Wright Jonathan V Formulation for insulin and glucose control
CN1792205B (zh) * 2004-12-24 2010-05-12 花王株式会社 绿茶提取物的精制品及其含高浓度儿茶素的容器装饮料
CN109549987A (zh) * 2017-09-25 2019-04-02 株式会社爱茉莉太平洋 用于保护细胞免受氧化应激的、包含具有改进量的成分的绿茶提取物的组合物
US11110145B2 (en) 2017-09-25 2021-09-07 Amorepacific Corporation Composition for protecting cell from oxidative stress comprising green tea extract which has modified amounts of ingredients

Similar Documents

Publication Publication Date Title
Williams et al. Observations on induced thiamine (vitamin B1) deficiency in man
Prichard et al. Treatment of hypertension with propranolol
US20190054136A1 (en) Dietary Supplement for the Treatment of Acid Reflux and Gastro-Oesophageal Reflux Disease (GORD/GERD)
CN101926483A (zh) 杞菊明目益智保健饮料
CN101507796B (zh) 治疗糖尿病及其慢性并发症的药茶
CN1346642A (zh) 降糖茶
CN102697135A (zh) 明目三降功能饮料
Jolliffe The diagnosis, treatment, and prevention of vitamin B1 deficiency
CN105147944B (zh) 一种中药组合物、其制剂及其制备方法和应用
CN109395045A (zh) 一种治疗2型糖尿病湿热中阻证的清热化湿调糖丸及其制备方法
CN110201100A (zh) 一种防治三高症、动脉硬化及肥胖症的药食同源组方
CN108576230A (zh) 一种辅助调节血糖、血脂奶粉的配方及制备方法
US6103242A (en) Method of controlling blood sugar levels using Coccoloba uvifera
CN104432158A (zh) 一种适合糖尿病人食用的保健食品及其制备方法
Tardner Ozempic vs Mounjaro For Weight Loss
CN104621304A (zh) 黄秋葵降糖茶及其生产工艺
Sethi Diabetes Control in your hands
Nazarko Treatment of type 2 diabetes
CN101947275B (zh) 一种用于治疗糖尿病的粉剂及其制备方法
Boyd The treatment of diabetic coma in children
CN103609765A (zh) 一种防治高血压疾病的泡袋剂
CN102475801A (zh) 一种治疗低血压的药物
Felchl Pulmonary Consumption, Bright’s Disease and Diabetes Mellitus
CN111149957A (zh) 一种适合于糖尿病患者饮用的饮料及制备方法
CN101991114A (zh) 一种益于糖尿病人服用的食膳

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication